Enzalutamide in Metastatic Prostate Cancer before Chemotherapy | Zendy

Tomasz M. Beer | Zendy; Andrew J. Armstrong | Zendy; Dana E. Rathkopf | Zendy; Yohann Loriot | Zendy; Cora N. Sternberg | Zendy; Celestia S. Higano | Zendy; Peter Iversen | Zendy; Suman Bhattacharya | Zendy; Joan Carles | Zendy; Simon Chowdhury | Zendy; Ian D. Davis | Zendy; Johann S. de Bono | Zendy; Christopher P. Evans | Zendy; Karim Fizazi | Zendy; Anthony M. Joshua | Zendy; ChoungSoo Kim | Zendy; Go Kimura | Zendy; Paul N. Mainwaring | Zendy; Harry H. Mansbach | Zendy; Kurt Miller | Zendy; Sarah B. Noonberg | Zendy; Frank Perabo | Zendy; De Phung | Zendy; Fred Saad | Zendy; Howard I. Scher | Zendy; MaryEllen Taplin | Zendy; Peter Venner | Zendy; Bertrand Tombal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Author(s) -

Tomasz M. Beer,

Andrew J. Armstrong,

Dana E. Rathkopf,

Yohann Loriot,

Cora N. Sternberg,

Celestia S. Higano,

Peter Iversen,

Suman Bhattacharya,

Joan Carles,

Simon Chowdhury,

Ian D. Davis,

Johann S. de Bono,

Christopher P. Evans,

Karim Fizazi,

Anthony M. Joshua,

ChoungSoo Kim,

Go Kimura,

Paul N. Mainwaring,

Harry H. Mansbach,

Kurt Miller,

Sarah B. Noonberg,

Frank Perabo,

De Phung,

Fred Saad,

Howard I. Scher,

MaryEllen Taplin,

Peter Venner,

Bertrand Tombal

Publication year - 2014

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1405095

Subject(s) - enzalutamide , prostate cancer , medicine , oncology , chemotherapy , cancer , androgen receptor

Enzalutamide is an oral androgen-receptor inhibitor that prolongs survival in men with metastatic castration-resistant prostate cancer in whom the disease has progressed after chemotherapy. New treatment options are needed for patients with metastatic prostate cancer who have not received chemotherapy, in whom the disease has progressed despite androgen-deprivation therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research